Both in Surgical Instruments
Tandem Diabetes Care vs PROCEPT BioRobotics
Over the past year TNDM returned +22.9% and PRCT returned −41.6%; their daily moves had a correlation of 0.29.
TNDM +22.9% PRCT −41.6%Growth of $1, one year, split-adjusted
| Metric | TNDM | PRCT |
|---|---|---|
| Price | $17.65 | $20.17 |
| Market cap | $1.23B | $1.16B |
| Today | −5.46% | +3.76% |
| 1 month | +6.8% | +13.2% |
| 6 months | −9.1% | −19.9% |
| Year to date | −19.7% | −35.9% |
| 1 year | +26.1% | −40.7% |
| Revenue growth (YoY) | +5.8% | +19.3% |
| Gross margin | 56.9% | 66.0% |
| Net margin | −8.3% | −28.4% |
| P/E (TTM) | — | — |
| Price / sales | 1.2× | 3.4× |
| Net cash | -$146.6M | $176.2M |
| Dividend yield | — | — |
| Volatility (60d) | 51.1% | 60.0% |
| Short % of float | 21.9% | 14.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).